Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers seek quicker, less invasive cancer detection
July 24th, 2005
A Mississippi State University (MSU) research team is developing a cancer screening process that may allow physicians to more quickly diagnose often-deadly malignancies without performing invasive biopsies. Using a novel technology called laser-induced breakdown spectroscopy, or LIBS, MSU engineers and biomedical scientists are seeking to precisely distinguish malignant and normal cells in real time by inserting a single optical fiber microprobe directly into suspicious tissue for a cancer diagnosis, including breast cancer. MSU is seeking a patent for the new technology devised by team leader Jagdish P. Singh, a research professor with the...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
